Compare TECH & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECH | RRC |
|---|---|---|
| Founded | 1976 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.9B |
| IPO Year | 1995 | 1996 |
| Metric | TECH | RRC |
|---|---|---|
| Price | $53.39 | $44.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 17 |
| Target Price | ★ $71.82 | $43.18 |
| AVG Volume (30 Days) | 2.0M | ★ 3.2M |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | 0.59% | ★ 0.92% |
| EPS Growth | N/A | ★ 151.38 |
| EPS | 0.49 | ★ 2.74 |
| Revenue | $1,219,635,000.00 | ★ $3,115,515,000.00 |
| Revenue This Year | $2.49 | $14.43 |
| Revenue Next Year | $6.40 | $10.53 |
| P/E Ratio | $109.85 | ★ $15.91 |
| Revenue Growth | 5.23 | ★ 28.90 |
| 52 Week Low | $46.02 | $30.32 |
| 52 Week High | $72.16 | $48.31 |
| Indicator | TECH | RRC |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 56.29 |
| Support Level | $49.48 | $34.07 |
| Resistance Level | $58.88 | $48.31 |
| Average True Range (ATR) | 1.97 | 1.62 |
| MACD | 0.59 | -0.42 |
| Stochastic Oscillator | 74.55 | 39.31 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.